The American Thyroid Association Recognizes Research Grant Collaboration of Patient Support Groups: Bite Me Cancer and Thyca: Thyroid Cancer Survivors’ Association, Inc.

Released: 22-Jul-2014 2:00 PM EDT
Source Newsroom: American Thyroid Association
Contact Information

Available for logged-in reporters only

Newswise — The American Thyroid Association (ATA) is proud to announce a newly awarded research grant in collaboration with Bite Me Cancer and the valuable continuing partnership with ThyCa: Thyroid Cancer Survivors’ Association, Inc. (ThyCa). The ATA is committed to supporting research by investigators leading to better discovery, diagnosis and treatment of thyroid disease and thyroid cancer. The generosity of members, patients, industry, and donors in the workplace has enabled the ATA to award over $3.6 million since the inception of the Research Fund. In support of the ATA Research program, ThyCa has provided funds for 47 special research grants focused on thyroid cancer and medullary thyroid cancer since 2003. The ATA awards 3 renewable grants annually, as well as providing the administrative and organizational support for the research grant program which includes management of its volunteer research committee offering scientific expertise, review and evaluation.

Bite Me Cancer is the newest member of the ATA Alliance for Patient Education and ThyCa is a founding member.

2014 ATA Research Grants
Tatiana de Lourdes Fonseca, PhD – Rush University Medical Center, Chicago, Illinois
What is the Role of Type II Deiodinase (D2)-Mediated T3 Production in Liver and its Repercussion to Energy Expenditure?

Leo Kim, MD, PhD – Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
Animal Models of Acute and Chronic Thyroid Eye Disease

Peter Taylor MB, ChB - Cardiff University, United Kingdom
The Impact of Maternal and Offspring Genetic Variants on Phenotypic Outcomes in the Controlled Antenatal Thyroid Screening Study (CATS).

W. Edward Visser, MD – Erasmus University Medical Center, Netherlands
Thyroid Hormone and Aging

2014 ATA ThyCa Grants
Elizabeth Grubbs, MD – The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Fusion Oncogenes as Drivers of Medullary Thyroid Cancer

Jason Prescott, MD, PhD – Johns Hopkins School of Medicine, Baltimore, Maryland
Development of a High Throughput in vivo Screening System for Small Molecule Activators of Thyroid Differentiation: Identification and Targeting of New Molecular Pathways Involved Thyroid Cancer Progression

Brian Untch, MD - Memorial Sloan-Kettering Cancer Center, New York, New York
Mechanisms of Response and Resistance to Farnesyltransferase Inhibition in HRAS-driven Thyroid Tumors

2014 ATA Bite Me Cancer Grant
Ramona Dadu, MD – The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Immune Markers in Medullary Thyroid Cancer (MTC) and Their Clinical Significance

2014 Second Year Grant Awardees:

ATA Research Grants
Jennifer Morrison, MD, PhD - University of Colorado - Denver, Colorado
TXNIP as a Regulator of Thyroid Cancer Aggressiveness

Joao Pedro Saar Werneck de Castro, PhD - University of Miami, Coral Gables, Florida
What is the Role Played by D2-mediated T3 Production in Skeletal Muscle?

Kevin Phillips, PhD - The Methodist Hospital Research Institute, Houston, Texas
The Contribution of Cyp7a1 to the Cholesterol Lowering Actions of TR Agonists

ATA ThyCa Grants – Medullary Thyroid Cancer
Nicole Chau, MD - Harvard Medical School, Boston, Massachusetts
Overcoming Resistance to RET inhibitors in Medullary Thyroid Cancer

ATA ThyCa Grants – Thyroid Cancer
Brittany Bohinc, MD - Duke University Hospital, Durham, North Carolina
Overexpression of LGR4 and LGR5 in Human Thyroid Cancer Promotes Wnt/β-Catenin Signaling and is Associated with Tumor Aggressiveness

Jaroslaw Jendrzejewski, MD - Ohio State University, Columbus, Ohio
Analysis of locus 14q13.3 in search of mutations predisposing to Papillary Thyroid Carcinoma (PTC)

###
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. ATA is an international individual membership organization with over 1,400 members from 43 countries around the world.

Celebrating its 91st anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, THYROID, Clinical Thyroidology, VideoEndocrinology and Clinical Thyroidology for the Public; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease.

More information about ATA is found at www.thyroid.org.


Comment/Share